Lymphoma, Low-Grade Completed Phase 1 / 2 Trials for Veltuzumab (DB05656)
Also known as: Low-Grade Lymphoma
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029914 (Lymphoma, Low-Grade) | Completed | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00546793 | Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL | Treatment |